Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 26, 2008

Lilly Beefs Up Biomarker Analysis Deal with HistoRx

  • Eli Lilly has gained broader use of HistoRx’ tissue biomarker analysis technology through a three-year extension. The expanded deal allows Lilly to increase its use of the Aqua® platform beyond the specified programs detailed in the 2005 agreement.

    Under the new alliance, HistoRx will also develop customized Aqua analysis-based immunohistochemical assays for Lilly to use in drug discovery and development projects.

    HistoRx has the option to commercialize the assays and reagents developed during the course of the partnership for clinical use as predictive diagnostics.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »